Our company has been present on the market since 2007. The scope of our activity includes training and courses in the field of Biofeedback as well as the distribution and implementation of tools and methods for conducting specialized diagnosis and therapy using neurotechnology. We also publish textbooks on neuroregulation, psychophysiology, diagnostics and dyslexia therapy.
For many years we have been conducting Biofeedback, EEG / QEEG, Warnke dyslexia therapy training, Rehacom cognitive rehabilitation training and EEG for neurotherapists, tDCS, and sensomotorics. We employ lecturers with many years of experience in working with children and adults, and able to patiently transfer their skills to training participants. We have Thought Technology world-class equipment. We run classes in small groups and a friendly atmosphere.
We are a distributor of equipment and software of the world's leading manufacturers such as MediTech, Neuroelectrics. We are the exclusive distributor of Thought Technology, Mitsar and Electrical Geodesics (EGI) equipment in Poland.
We are constantly making efforts to spread the methods we use.
All interested are welcome to contact us.
47.74.Z - Retail sale of medical and orthopedic products
33.13.Z - Repair and maintenance of electronic and optical devices
47.41.Z - Retail trade
47.91.Z - Intermediary retail sale, non-specialized
47.99.Z - Retail trade
58.19.Z - Other publishing activities, excluding software publishing
77.39.Z - Rental and leasing of other machinery, equipment, and tangible assets, not elsewhere classified
82.30.Z - Activities related to organizing fairs, exhibitions, and congresses
85.59.B - Courses and training for acquiring knowledge, skills, and professional qualifications in non-school forms
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 1,8 | 1,2 | 1,8 | 53 |
EBITDA | 1,9 | 1,2 | 1,8 | 49,6 |
Short time liabilities | 1,1 | 1,1 | 1,2 | 3,9 |
Equity capital | 2,7 | 2,2 | 3 | 35,5 |
Operating profit (EBIT) | 1,8 | 1,2 | 1,8 | 53,5 |
Assets | 3,8 | 3,3 | 3,2 | -4,9 |
Net profit (loss) | 1,8 | 1,2 | 1,8 | 53 |
Cash | 2,9 | 2 | 2,1 | 5,7 |
Net income from sale | 8,4 | 8,1 | 8,1 | 0,1 |
Liabilities and provisions for liabilities | 0 | 0 | 1,1 | -∞ |
Working assets | 3,8 | 3,3 | 3,2 | -4,8 |
Depreciation | 0,1 | 0 | 0 | -76,7 |
% | % | % | p.p. | |
Profitability of capital | 68,3 | 52,9 | 59,8 | 6,9 |
Equity capital to total assets | 80,1 | 66,4 | 100 | 33,6 |
Gross profit margin | 21,8 | 14,5 | 22,1 | 7,6 |
EBITDA Margin | 22,7 | 14,9 | 22,2 | 7,3 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 49 | 50 | 52 | 2 |
Current financial liquidity indicator | 3.3356120586395264 | 2.968755006790161 | 2.7281665802001953 | -0,3 |
Net dept to EBITDA | -1.5034382343292236 | -1.6532292366027832 | -1.1680488586425781 | 0,5 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane